Ginkgo biloba leaves extract
A plant extract.
Potential treatment - pre-clinical evidence
Ginkgo biloba leaves extract was observed to inhibit SARS-CoV-2 3C-like protease (Xiong et al., 2021).
|Link||Tested on||Impact factor||Notes||Publication date|
Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening
3CLpro Enzyme assay In vitro In silico
|in silico; in vitro enzyme assay||2.53||
The extract inhibited SARS-CoV-2 3C-like protease with an IC50 of 6.68 μg/ml.